Fig. 5: Risk of bias assessments for each paper category. Bias was assessed using Covidence’s Cochrane risk of bias tool. | Communications Medicine

Fig. 5: Risk of bias assessments for each paper category. Bias was assessed using Covidence’s Cochrane risk of bias tool.

From: Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Fig. 5: Risk of bias assessments for each paper category. Bias was assessed using Covidence’s Cochrane risk of bias tool.The alternative text for this image may have been generated using AI.

For sequence generation, allocation concealment, and blinding categories, raters had the option of selecting high quality (green), low quality (orange), not reported (red), or that a decision could not be made because of primary trial was referenced in methods (yellow). For incomplete outcome data, raters only had the option to choose high quality/data provided (green) or low quality/data not provided (red). For selective reporting, raters had the option to select high-quality/primary endpoint predefined (green), low-quality/primary endpoint not defined (orange), or low-quality/not reported (red). For other sources of bias, raters had the option to select high quality/none (green), low quality/bias present but identified and considered (orange), or low quality/obvious bias present and not addressed (red). Data are shown as absolute frequencies.

Back to article page